FIELD: genetic engineering, medicinal genetics. SUBSTANCE: set of recombinant plasmid DNA consists of 4 plasmid DNA. pYAI 11-19 is genome fragment of human DNA of size 1500 nucleotide pairs and involves 4 internal unique restriction site Eco RI. DNA fragment is limited by Pst I-sites from different ends of genome fragment. Under "mild" conditions this probe DNA is hybridized with centromere regions of chromosomes 1, 3, 5, 6, 7, 10, 12, 16, 19 or under "rigid" conditions with centromere region of chromosome 10 only. pYAI 2-45 is genome fragment of human DNA of size 1100 nucleotide pairs, involves 3 internal unique restriction site Eco RI and limited by Pst I-sites from different ends of genome fragment. Under "mild" conditions this probe DNA is hybridized with centromere regions of chromosomes 2, 4, 8, 9, 18, 20 but under "rigid" conditions with centromere region of chromosome 4 only. pYS 37 is genome fragment of human DNA of size 680 nucleotide pairs, involves 2 internal unique restriction sites Eco RI and limited by Pst I-sites from different ends of genome fragment. Under "mild" conditions this probe DNA is hybridized with centromere regions of chromosomes 13, 14, 15, 21, 22, Y but under "rigid" conditions with centromere regions of chromosomes 13 and 21 only. pYAI 7-29 is genome fragment of human DNA of size 2700 nucleotide pairs, involves 7 internal unique restriction sites Eco RI and limited by Pst I-sites from different ends of genome fragment. Under "mild" conditions this probe DNA is hybridized with centromere regions of chromosomes 1, 11, 17, X but under "rigid" conditions with centromere region of chromosome 17 only. Invention ensures to determine origin of human accessory or marker (mini-) chromosomes in practice of medicinal genetics, namely, in prenatal diagnosis, clinical cytogenetics and oncocytogenetics. EFFECT: improved method of determination. 3 ex
Title | Year | Author | Number |
---|---|---|---|
RECOMBINANT PLASMID DNA PYAI 960 DESIGNATED FOR HUMAN 18-TH CHROMOSOME MARKING | 2000 |
|
RU2161199C1 |
RECOMBINANT PLASMID DNA ALPHA R 1-6 DESIGNATED FOR MARKING THE 13-TH AND 21-D HUMAN CHROMOSOMES | 1995 |
|
RU2087534C1 |
RECOMBINANT PLASMID DNA PYAIA05 FOR MARKING AND IDENTIFICATION OF THE THIRD HUMAN CHROMOSOME | 1994 |
|
RU2087533C1 |
RECOMBINANT PLASMID DNA pYAII-39, USED FOR 4TH AND 9TH HUMAN CHROMOSOME MARKING IN METAPHASIC AND INTERPHASIC CELLS | 2006 |
|
RU2325441C1 |
RECOMBINANT PLASMID DNA ALPHA-R-12 DESIGNATED FOR MARKING 6-TH HUMAN CHROMOSOME IN METAPHASE IN INTERPHASE CELLS | 2004 |
|
RU2265060C1 |
RECOMBINANT PLASMID DNA ALPHA RI-7 FOR LABELLING OF THE FIRST HUMAN CHROMOSOME | 0 |
|
SU1792429A3 |
METHOD OF MARKING HUMAN 7TH CHROMOSOME IN METAPHASIC AND INTERPHASIC CELLS | 2009 |
|
RU2425890C2 |
METHOD OF LABELLING MANЪS 11TH CHROMOSOME,RECOMBINATION PLASMIDE OF GENOME DEOXYRIBONUCLEIC ACID PHS 53 FOR LABELLING AND METHOD OF PRODUCING FRAGMENT OF DEOXYRIBONUCLEIC ACID PHS 53 | 0 |
|
SU1203108A1 |
METHOD OF DETERMINING QUANTITY OF X-CHROMOSOME OF MAN | 0 |
|
SU1494724A1 |
METHOD FOR DETERMINING RISK OF ECOLOGICALLY MEDIATED CHILDREN NEPHROPATHY FORMATION | 1999 |
|
RU2160446C1 |
Authors
Dates
2003-03-20—Published
2002-04-01—Filed